Clinical Trial Update: Success Rate Evaluation of Miniature Pulpotomy With MTA in Primary Molars [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the success rate of miniature pulpotomy with mineral trioxide aggregate (MTA) in primary molars.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulpitis

Drugs mentioned

• Mineral Trioxide Aggregate (MTA) (Mineral Trioxide Aggregate)

Snippet

Sponsor: Mashhad University of Medical Sciences | Conditions: Pulpitis, Dental Pulp Disease | Phase 4 | Status: UNKNOWN